M&A Deal Summary

Hologic Acquires Gynesonics

On October 14, 2024, Hologic acquired medical products company Gynesonics from HBM Partners AG for 350M USD

Acquisition Highlights
  • This is Hologic’s 19th transaction in the Medical Products sector.
  • This is Hologic’s 6th largest (disclosed) transaction.
  • This is Hologic’s 18th transaction in the United States.
  • This is Hologic’s 5th transaction in California.

M&A Deal Summary
Date 2024-10-14
Target Gynesonics
Sector Medical Products
Buyer(s) Hologic
Sellers(s) HBM Partners AG
Deal Type Add-on Acquisition
Deal Value 350M USD

Target

Gynesonics

Redwood City, California, United States
Gynesonics is a medical device company, develops minimally invasive therapeutic device to treat uterine fibroids in women. Gynesonics was founded in 2005 and is based in Redwood City, California.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Hologic

Marlborough, Massachusetts, United States
Category Company
Founded 1985
Sector Medical Products
Employees6,944
Revenue 4.0B USD (2023)
DESCRIPTION
Hologic's corporate headquarters in Marlborough, Massachusetts.
Hologic's corporate headquarters in Marlborough, Massachusetts.

Hologic is a developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women throughout the world. Hologic was formed in 1985 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 25 of 25
Sector (Medical Products) 19 of 19
Type (Add-on Acquisition) 23 of 23
State (California) 5 of 5
Country (United States) 18 of 18
Year (2024) 2 of 2
Size (of disclosed) 6 of 24
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-04-29 Endomagnetics

Cambridge, United Kingdom

Endomagnetics develops and sells breast surgery localization and lymphatic tracking technologies. Endomagnetics is based in Cambridge, United Kingdom.

Buy $310M

Seller(S) 1

SELLER

HBM Partners AG

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2001
PE ASSETS 3.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

HBM Partners is a private investment firm focused on investing in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. HBM looks to invest $5 to $50 million per transaction and will consider private and public companies. HBM Partners was established in 2001 and is headquartered in Zug, Switzerland.

DEAL STATS #
Overall 35 of 35
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 5 of 5
State (California) 9 of 9
Country (United States) 27 of 27
Year (2024) 3 of 3
Size (of disclosed) 4 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-10-14 Longboard Pharmaceuticals

La Jolla, California, United States

Longboard Pharmaceuticals is a clinical-stage biopharmaceutical company, focuses on developing medicines for neurological diseases. Its products include LP352, a Phase I clinical trial product for the developmental and epileptic encephalopathies (DEEs) and refractory epilepsies; LP143, a product for amyotrophic lateral sclerosis and other neuroinflammatory disorders; and LP659, a product for multiple neuroinflammatory disorders. Longboard Pharmaceuticals was founded in 2020 and is based in La Jolla, California.

Sell $2.6B
Mergr

Product

Company

Legal